Johnson & Johnson has been ordered to pay $1 billion in damages to Auris Health shareholders for failing to meet commitments in a 2019 acquisition agreement. The Delaware Court of Chancery found that J&J’s actions hindered the development of Auris’ iPlatform technology, which was crucial for earning additional payments to investors.